Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sprung

Showing results (171-180 of 223) with videos related to

Pageof 23
Sort By:
JAMA|August 14, 2003
End-of-life practices in European intensive care units: the Ethicus StudyCharles L Sprung, Simon L Cohen, Peter Sjokvist, et al.
Intensive Care Medicine|June 2, 2007
The importance of religious affiliation and culture on end-of-life decisions in European intensive care unitsCharles L Sprung, Paulo Maia, Hans-Henrik Bulow, et al.
Intensive Care Medicine|February 27, 2017
The status of intensive care medicine research and a future agenda for very old patients in the ICUH Flaatten, D W de Lange, A Artigas, et al.
Critical Care Medicine|December 15, 2006
Survival of critically ill patients hospitalized in and out of intensive careElisheva Simchen, Charles L Sprung, Noya Galai, et al.
Medical Image Analysis|January 26, 2000
Experimentation with a transcranial magnetic stimulation system for functional brain mappingG J Ettinger, M E Leventon, W E Grimson, et al.
Intensive Care Medicine|August 9, 2013
Triage of intensive care patients: identifying agreement and controversyCharles L Sprung, Marion Danis, Gaetano Iapichino, et al.
The Journal of Infectious Diseases|December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levelsC H Wortel, M A von der Möhlen, S J van Deventer, et al.
Intensive Care Medicine|May 1, 1994
HA-1A in septic patients with ARDS: results from the pivotal trialL M Bigatello, R E Greene, C L Sprung, et al.
Intensive Care Medicine|November 10, 2007
Reasons, considerations, difficulties and documentation of end-of-life decisions in European intensive care units: the ETHICUS StudyCharles L Sprung, Thomas Woodcock, Peter Sjokvist, et al.
The New England Journal of Medicine|February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study GroupE J Ziegler, C J Fisher, C L Sprung, et al.
Pageof 23

Showing results (171-180 of 223) with videos related to

Sort By:
Pageof 23
JAMA|August 14, 2003
End-of-life practices in European intensive care units: the Ethicus StudyCharles L Sprung, Simon L Cohen, Peter Sjokvist, et al.
Intensive Care Medicine|June 2, 2007
The importance of religious affiliation and culture on end-of-life decisions in European intensive care unitsCharles L Sprung, Paulo Maia, Hans-Henrik Bulow, et al.
Intensive Care Medicine|February 27, 2017
The status of intensive care medicine research and a future agenda for very old patients in the ICUH Flaatten, D W de Lange, A Artigas, et al.
Critical Care Medicine|December 15, 2006
Survival of critically ill patients hospitalized in and out of intensive careElisheva Simchen, Charles L Sprung, Noya Galai, et al.
Medical Image Analysis|January 26, 2000
Experimentation with a transcranial magnetic stimulation system for functional brain mappingG J Ettinger, M E Leventon, W E Grimson, et al.
Intensive Care Medicine|August 9, 2013
Triage of intensive care patients: identifying agreement and controversyCharles L Sprung, Marion Danis, Gaetano Iapichino, et al.
The Journal of Infectious Diseases|December 1, 1992
Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levelsC H Wortel, M A von der Möhlen, S J van Deventer, et al.
Intensive Care Medicine|May 1, 1994
HA-1A in septic patients with ARDS: results from the pivotal trialL M Bigatello, R E Greene, C L Sprung, et al.
Intensive Care Medicine|November 10, 2007
Reasons, considerations, difficulties and documentation of end-of-life decisions in European intensive care units: the ETHICUS StudyCharles L Sprung, Thomas Woodcock, Peter Sjokvist, et al.
The New England Journal of Medicine|February 24, 1991
Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study GroupE J Ziegler, C J Fisher, C L Sprung, et al.
Pageof 23